The Outcome of Hospital-Acquired Bloodstream Infection and Its Associated Factors in Critical Care Unit

Overview

Journal Malays J Med Sci

Date 2025 Jan 20

PMID 39830098

Authors

Nurul Rahatul Ilyani Mohamed Shukri

Shamsul Kamalrujan Hassan

Siti Suraiya Md Noor

Siti Azrin Ab Hamid

Nik Abdullah Nik Mohamad

Wan Fadzlina Wan Muhd Shukeri

Mohd Zulfakar Mazlan

Affiliations

Soon will be listed here.

Abstract

Background: Hospital-acquired bloodstream infections (BSI) are associated with high morbidity and mortality rates. This study was conducted to describe the outcomes and the prognosis of hospital-acquired BSI in the Critical Care Unit, Hospital Pakar Universiti Sains Malaysia (HPUSM), as well as to identify associated factors of treatment failure and mortality at 28 days.

Methods: This prospective cohort study was conducted in the Critical Care Unit of HPUSM from September 2019 to March 2021. Eligible participants included patients with a positive blood culture recorded after 48 hours of admission to hospital.

Results: There was a total of 250 patients, whose positive blood cultures were isolated. The main isolated organisms were (23.6%), spp. (19.2%), (12.8%) and (9.2%). The mortality of hospital-acquired BSI was 27.6%. Multiple logistic regression analysis revealed that age [adjusted odds ratio (OR) = 1.06; 95% confidence interval (CI): 1.03, 1.09; < 0.001], cases with extended-spectrum beta-lactamases (ESBL) (adjusted OR = 5.57; 95% CI: 2.04, 15.21; = 0.001), with multidrug-resistant (MDR) organisms (adjusted OR = 14.70; 95% CI: 3.97, 54.48; < 0.001) and those with a sequential organ failure assessment (SOFA) score > 11 (adjusted OR = 4.16; 95% CI: 1.31, 13.19; = 0.015) had statistically significant associations with treatment failure. Factors significantly associated with 28-day mortality included age (adjusted OR: 1.06: 95% CI; 1.03, 1.09; < 0.001), MDR organisms (adjusted OR = 14.70; 95% CI: 3.97, 54.48; < 0.001) and SOFA score > 11 (adjusted OR = 4.16; 95% CI: 1.31, 13.19; = 0.015).

Conclusion: The elderly, ESBL, MDR organisms and high SOFA scores were associated with treatment failure and 28-day mortality in hospital-acquired BSI.

References

Gupta V, Yassin M . Infection and hemodialysis access: an updated review. Infect Disord Drug Targets. 2013; 13(3):196-205. DOI: 10.2174/1871526511313030008. View

Leu H, Kaiser D, Mori M, Woolson R, Wenzel R . Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol. 1989; 129(6):1258-67. DOI: 10.1093/oxfordjournals.aje.a115245. View

Blot S, Vandewoude K, De Bacquer D, Colardyn F . Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis. 2002; 34(12):1600-6. DOI: 10.1086/340616. View

Pittet D, Li N, Woolson R, Wenzel R . Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis. 1997; 24(6):1068-78. DOI: 10.1086/513640. View

Valles J, Leon C, Alvarez-Lerma F . Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis. 1997; 24(3):387-95. DOI: 10.1093/clinids/24.3.387. View

Laupland K, Lee H, Gregson D, Manns B . Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect. 2006; 63(2):124-32. DOI: 10.1016/j.jhin.2005.12.016. View

Roberts F, Geere I, Coldman A . A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis. 1991; 13(1):34-46. DOI: 10.1093/clinids/13.1.34. View

Deptula A, Gospodarek E . Reduced expression of virulence factors in multidrug-resistant Pseudomonas aeruginosa strains. Arch Microbiol. 2009; 192(1):79-84. DOI: 10.1007/s00203-009-0528-1. View

Hobby G, Karaduta O, Dusio G, Singh M, Zybailov B, Arthur J . Chronic kidney disease and the gut microbiome. Am J Physiol Renal Physiol. 2019; 316(6):F1211-F1217. PMC: 6620595. DOI: 10.1152/ajprenal.00298.2018. View

10.

Krcmery Jr V, Spanik S, Krupova I, Trupl J, Kunova A, Smid M . Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study. J Chemother. 1998; 10(4):320-5. DOI: 10.1179/joc.1998.10.4.320. View

11.

Balkan I, Aygun G, Aydin S, Mutcali S, Kara Z, Kuskucu M . Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival. Int J Infect Dis. 2014; 26:51-6. DOI: 10.1016/j.ijid.2014.05.012. View

12.

Tabah A, Koulenti D, Laupland K, Misset B, Valles J, de Carvalho F . Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med. 2012; 38(12):1930-45. DOI: 10.1007/s00134-012-2695-9. View

13.

Choi G, Gomersall C, Tian Q, Joynt G, Freebairn R, Lipman J . Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med. 2009; 37(7):2268-82. DOI: 10.1097/CCM.0b013e3181aab3d0. View

14.

Pittet D, Tarara D, Wenzel R . Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994; 271(20):1598-601. DOI: 10.1001/jama.271.20.1598. View

15.

Roder B, Nielsen S, Magnussen P, Engquist A, Frimodt-Moller N . Antibiotic usage in an intensive care unit in a Danish university hospital. J Antimicrob Chemother. 1993; 32(4):633-42. DOI: 10.1093/jac/32.4.633. View

16.

Musicha P, Cornick J, Bar-Zeev N, French N, Masesa C, Denis B . Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study. Lancet Infect Dis. 2017; 17(10):1042-1052. PMC: 5610140. DOI: 10.1016/S1473-3099(17)30394-8. View

17.

Sanchez Garcia M . Early antibiotic treatment failure. Int J Antimicrob Agents. 2009; 34 Suppl 3:S14-9. DOI: 10.1016/S0924-8579(09)70552-7. View

18.

Dimick J, Pelz R, Consunji R, Swoboda S, Hendrix C, Lipsett P . Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001; 136(2):229-34. DOI: 10.1001/archsurg.136.2.229. View

19.

Prowle J, Echeverri J, Ligabo E, Sherry N, Taori G, Crozier T . Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care. 2011; 15(2):R100. PMC: 3219371. DOI: 10.1186/cc10114. View

20.

de Kraker M, Davey P, Grundmann H . Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011; 8(10):e1001104. PMC: 3191157. DOI: 10.1371/journal.pmed.1001104. View